#TAVR #Patients #Hispanic
Written By: Adam Pick, Patient Advocate & Author
Published: September 18, 2023; This post is sponsored by Medtronic
Aortic stenosis is a life-threatening disease that is under-diagnosed and under-treated. In fact, the survival rate is just 50% at two years for patients diagnosed with symptomatic severe aortic stenosis. To make matters worse, only 3.4% of patients that receive non-invasive transcatheter aortic valve replacement (TAVR) are Hispanic.
How and why is Medtronic, a leading manufacturer of TAVR devices, taking big steps to treat more Hispanic patients like Mrs. Julia Garcia? Click this link to find out.
Many Thanks to Julia and Medtronic!
Many thanks to Julia for sharing their wonderful TAVR success story with our community!
A special thanks goes out to Medtronic for their commitment to removing barriers that prevent patients from life-saving procedures for aortic stenosis. We are so appreciative of Medtronic’s dedication to advancing valvular therapy and Medtronic’s initiatives to expand treatment for minorities.
Keep on tickin Julia!